Guangzhou LBP Medicine Science & Technology Co., Ltd.

Guangzhou LBP Medicine Science & Technology Co., Ltd. (LBP SYSTEM) was founded in 2005, is China's first publicly listed company in the pathological diagnosis field(Stock Code: 688393). Focused on products and services for tumor screening and precision diagnosis.

We have independently developed supporting equipment and reagent consumables across technology platforms including Liquid-Based Cytology (LBC), Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), and Digital Pathology & Artificial Intelligence (DP&AI).